Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs.
The Biopharmaceutics Classification System (BCS) categorizes drugs into one of four biopharmaceutical classes according to their water solubility and membrane permeability characteristics and broadly allows the prediction of the rate-limiting step in the intestinal absorption process following oral administration. Since its introduction in 1995, the BCS has generated remarkable impact on the global pharmaceutical sciences arena, in drug discovery, development, and regulation, and extensive validation/discussion/extension of the BCS is continuously published in the literature. The BCS has been effectively implanted by drug regulatory agencies around the world in setting bioavailability/bioequivalence standards for immediate-release (IR) oral drug product approval. In this review, we describe the BCS scientific framework and impact on regulatory practice of oral drug products and review the provisional BCS classification of the top drugs on the global market. The Biopharmaceutical Drug Disposition Classification System and its association with the BCS are discussed as well. One notable finding of the provisional BCS classification is that the clinical performance of the majority of approved IR oral drug products essential for human health can be assured with an in vitro dissolution test, rather than empirical in vivo human studies.
Dahan
Arik
A
University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109-1065, USA.
Miller
Jonathan M
JM
Amidon
Gordon L
GL
D001702:Biopharmaceutics / Q000592:standards*; D003198:Computer Simulation; D005544:Forecasting; D006801:Humans; D010539:Permeability; D004364:Pharmaceutical Preparations / Q000145:classification* / Q000378:metabolism*; D010599:Pharmacokinetics; D012995:Solubility
D004364:Pharmaceutical Preparations